Filter
13570
Filtered Results: 13570
Text search:
national
health
act
Featured
Recommendations
1061
New Publications
3450
Language
Document type
No document type
7461
Studies & Reports
2364
Guidelines
1722
Manuals
653
Strategic & Response Plan
502
Fact sheets
326
Training Material
226
Situation Updates
160
Resource Platforms
51
Infographics
40
Brochures
38
Online Courses
24
Dashboards/Maps
1
App
1
Videos
1
Countries / Regions
India
554
Global
518
Kenya
361
Ethiopia
267
Latin America and the Carribbean
265
South Africa
263
Sierra Leone
246
Uganda
240
Nepal
239
Nigeria
233
Western and Central Europe
220
Liberia
211
Myanmar / Burma
190
Congo, Democratic Republic of
189
Africa
185
Rwanda
183
Malawi
174
Bangladesh
171
Zambia
170
Senegal
168
Tanzania
160
Ghana
146
Syria
144
Ukraine
143
Burkina Faso
113
Philippines
109
Haiti
108
Mozambique
103
Venezuela
102
Brazil
96
Indonesia
94
Namibia
93
South Sudan
91
Guinea
89
Colombia
89
Zimbabwe
88
Eastern Europe
87
Benin
86
Cambodia
84
Paraguay
83
Lesotho
78
West and Central Africa
78
Argentina
70
Cameroon
68
South–East Asia Region
68
Russia
67
Germany
64
Asia
64
Yemen
60
East and Southern Africa
60
Middle East and North Africa
56
Peru
55
Madagascar
52
Central African Republic
49
Botswana
48
Afghanistan
44
Pakistan
43
Eastern Europe and Central Asia
42
Mali
39
Chile
39
Eswatini/ Swaziland
37
Ecuador
36
Somalia
30
Bolivia
30
Lebanon
27
Sudan
27
Thailand
25
Jordan
24
Angola
24
Côte d’Ivoire / Ivory Coast
23
Niger
23
Vietnam
23
Western Pacific Region
22
Tajikistan
22
USA
21
China
20
Togo
19
Iraq
19
Moldova
17
Sri Lanka
16
Spain
16
Guinea-Bissau
15
Albania
15
Chad
14
Laos
14
Turkey
13
El Salvador
13
Mexico
13
Burundi
12
Libya
12
Georgia
12
Papua New Guinea
11
Palestine
11
North America
11
Egypt
10
North Macedonia
10
Southern Africa
9
Iran
9
Honduras
8
Guatemala
8
Kyrgyzstan
8
United Kingdom
8
Morocco
7
Greece
7
Poland
7
Armenia
7
Romania
7
Kazakhstan
7
Jamaica
7
Gambia
6
Nicaragua
6
Timor Leste/ East Timor
6
Tunisia
6
Portugal
6
Malaysia
5
Dominican Republic
5
Serbia
5
Hungary
5
Bhutan
5
Uruguay
5
Turkmenistan
5
France
5
Belarus
5
Saudi Arabia
4
Mauritania
4
Fiji
4
Congo-Brazzaville
4
Canada
4
Uzbekistan
4
Japan
4
Ireland
3
Singapore
3
Vanuatu
3
Switzerland
3
Croatia
3
Italy
3
Djibouti
3
Mongolia
3
Qatar
3
Estonia
3
Mauritius
3
Israel
3
Bosnia and Herzegovina
3
Other region
2
Solomon Islands
2
North Korea
2
Bulgaria
2
Lithuania
2
Slovakia
2
Gabon
2
Belgium
2
Azerbaijan
2
Austria
1
Cuba
1
Australia
1
Denmark
1
Maldives
1
Norway
1
South Korea
1
Algeria
1
French Guyana
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
5468
Clinical Guidelines
879
Public Health
679
Women & Child Health
651
Key Resources
553
Capacity Building
228
Pharmacy & Technologies
127
Annual Report MEDBOX
1
Toolboxes
COVID-19
1335
Mental Health
1035
HIV
918
TB
705
Planetary Health
509
Disability
499
Rapid Response
403
Ebola
400
AMR
382
Conflict
355
Caregiver
348
NTDs
290
Refugee
249
NCDs
240
Pharmacy
236
Global Health Education
228
Natural Hazards
178
Health Financing Toolbox
121
Zika
102
Polio
88
Cholera
80
Specific Hazards
71
Social Ethics
43
Typhoon
11
Health Financing
3
South Sudan
2
Buruli Ulcer Prevention of Disability (POD)
recommended
This manual is for use by doctors, nurses, rehabilitation specialists, National Buruli ulcer Control Programme managers and other health workers involved in the prevention of disability ...ivities in Buruli ulcer.
Birth defect has been an emerging major cause of child mortality in the region. Scarcity of the birth defects information hampers policy decisions and control measures at national level. In order to create evidence for ...ion for birth defects prevention in the region, WHO-SEARO in collaboration with CDC, USA has developed and launched a regional electronic database on birth defects. This surveillance database allows data collection on newborn health, birth defects and stillbirths cases and provides real time information at hospitals and national level.
Training of the hospital health staffs and data managers in the birth defects surveillance network; at regional, national and at hospital levels is recognized as essential for expansion of this database and to assure quality of data. A two days training module for hospital based birth defects surveillance was developed using a guide for operation and facilitator guide.
Training of the hospital health staffs and data managers in the birth defects surveillance network; at regional, national and at hospital levels is recognized as essential for expansion of this database and to assure quality of data. A two days training module for hospital based birth defects surveillance was developed using a guide for operation and facilitator guide.
The Global Antimicrobial Resistance Surveillance System (GLASS) is a platform for global data sharing on antimicrobial resistance worldwide. It has been launched by WHO as part of the implementation of the Global Action Plan on Antimicrobial Resista...
13 July 2021
The module provides an overview of factors to consider when monitoring the safety of COVID-19 vaccines administered to pregnant and breastfeeding women. It describes how national routine AEFI surveillance should be adapted to cater fo...
El objetivo de esta publicación es ofrecer un enfoque práctico y gradual para la aplicación de los planes de acción nacionales sobre la RAM en el sector de la salud humana; y proporcionar un proceso y una recopilación de las herramientas existentes de la OMS para priorizar, costear, aplicar, su...
This short document summarizes the key content of the WHO report Reducing the harm from alcohol by regulating cross-border alcohol marketing, advertising and promotion. It outlines the way that alcohol is being marketed across national borders – o...
Since 1996, trachoma has been targeted for elimination as a public health problem worldwide. The active trachoma criterion for national elimination...
En 2014, la soixante-septième Assemblée Mondiale de la Santé a exprimé sa préoccupation croissante au sujet de la situation
de la RAM, et elle a exhorté les pays membres à renforcer leurs programmes d’action ... ainsi que la collaboration
internationale. Dans sa résolution WHA67.25 l’Organisation Mondiale de la Santé (OMS) a recommandé que soit développé
un Plan d’Action Mondial pour lutter contre la RAM. Ce Plan a été adopté en mai 2015 et recommande notamment la mise en
place d’un système mondial de surveillance de la RAM (GLASS, Global Antimicrobial Résistance Surveillance System). L’objectif
de GLASS est de permettre la collecte, l’analyse et l’échange avec les pays de données standardisées, validées, comparables
sur la résistance aux antimicrobiens.
The 2021 COVID-19 Strategic Preparedness and Response Plan (SPRP) for AFR serves as a regional guide for a holistic public health response to COVID‑19 at regional, national and sub-... levels. The 2021
SPRP:
1. Builds upon the lessons learnt from the implementation of the 2020 SPRP and outlines a regional preparedness, response and recovery strategy for COVID‑19.
2. Has been adapted to reflect the Regional context including COVID-19 vaccination. It also considers epidemiological changes and recommen-dations emerging from the evaluation report of the 2020 SPRP4.
3. Highlights to Member States strategic preparedness and response actions to be sustained at national and sub-national levels, as well as the critical inter-agency and partner support required.
4. provides the indicative resource requirements to reinforce WHO planned interventions in the African Region to enhance countries’ capacities to suppress transmission, save lives and mitigate the impact of the pandemic on people and health systems.
5. Provides a road map for mitigating potential resurgence in the Region as economies reopen and ensure country level continuity of other essential health services.
This document outlines the working structure and guiding principles for collaboration of COVAX, the Vaccines pillar of the Access to COVID-19 Tools Accelerator (ACT-A). The working structure of COVAX continues to adapt to emerging needs and the chan...
In light of the decline in new Ebola cases, strategies are now needed to scale down the activities and bed capacities in Ebola care facilities. These facilities include Ebola treatment units, community care centres, Ebola treatment centres and isola...
Le présent document de travail a été conçu pour offrir des conseils pratiqueset des suggestions sur la manièred’établir et de maintenir la collaboration multisectorielle nécessaire pour élaborer et mettre en œuvre les plans d’action nat...
This global status report on prevention and control of NCDs (2014), is framed around the nine voluntary global targets. The report provides data on the current situation, identifying bottlenecks as well as opportunities and priority actions for atta...
The World Health Organization and the Global Fund to Fight AIDS, Tuberculosis and Malaria are part of a group of agencies working together to accelerate progress towards the health-related SDGs thro...
Plus de 700 000 personnes perdent la vie par suicide chaque année. La réduction d’un tiers du taux mondial de mortalité par suicide d’ici à 2030 est à la fois un indicateur et une cible (la seule pour la santé mentale) dans les objectifs de développement durable des Nations Unies et dans ...
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging partic...
Working Document Nov. 2020
The COVAX Supply and Logistics workstream lead by UNICEF, Gavi and WHO have released a working copy of the COVID-19 Vaccination, Country Readiness & Delivery: Supply and Logistics Guidance. Countries might find this Guide useful when developing and strengthening their sup...
This technical guidance outlines current evidence, knowledge and best practice relating to incidences of violence and injuries among refugees and migrants in the WHO European Region. It highlights key principles, summarizes priority actions and chal...
Pharmaceutical regulators are at the forefront of ensuring that only safe and effective medicines are authorized and available in the market. This document builds on the recommendations in the above publication and has been prepared to specifically assist ... medicines regulatory authorities to understand the nature and extent of oxytocin quality issues and to provide key technical information and quality requirements for oxytocin products in dossier assessments. Furthermore, this document also presents recommendations on other regulatory actions needed to ensure that only quality-assured oxytocin products are authorized and made available to women.
Based on scientific evidence, expert consensus and country experiences, the WHO core components for infection prevention and control (IPC) are the foundation for establishing or strengthening effective programmes at the national and facility level.
...
